S Shu

3.2k total citations · 1 hit paper
33 papers, 2.6k citations indexed

About

S Shu is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, S Shu has authored 33 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 24 papers in Oncology and 10 papers in Biotechnology. Recurrent topics in S Shu's work include Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (18 papers) and Cancer Research and Treatments (10 papers). S Shu is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (18 papers) and Cancer Research and Treatments (10 papers). S Shu collaborates with scholars based in United States, Malaysia and China. S Shu's co-authors include Alfred E. Chang, James J. Mulé, Steven A. Rosenberg, Ting‐Chao Chou, S A Rosenberg, Gregory E. Plautz, Bernard A. Fox, Hirohisa Yoshizawa, Gary J. Nabel and E G Nabel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

S Shu

31 papers receiving 2.5k citations

Hit Papers

Direct gene transfer with DNA-liposome complexes in melan... 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
    1993 692 citations Gary J. Nabel, E G Nabel et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Shu United States 23 1.7k 1.2k 815 569 189 33 2.6k
Suyu Shu United States 36 3.0k 1.8× 2.0k 1.7× 800 1.0× 413 0.7× 194 1.0× 95 3.8k
Glen Dranoff United States 10 2.7k 1.5× 1.7k 1.4× 1.1k 1.3× 786 1.4× 294 1.6× 13 3.4k
James G. McArthur United States 18 1.5k 0.9× 885 0.7× 802 1.0× 684 1.2× 52 0.3× 30 2.6k
Mariella Parenza Italy 21 1.4k 0.8× 758 0.6× 757 0.9× 339 0.6× 142 0.8× 27 2.2k
Judy Kantor United States 23 1.0k 0.6× 488 0.4× 686 0.8× 481 0.8× 131 0.7× 31 1.6k
Aron D. Thall United States 27 1.4k 0.8× 819 0.7× 900 1.1× 716 1.3× 72 0.4× 56 3.4k
Hy Levitsky United States 7 2.2k 1.3× 1.5k 1.2× 949 1.2× 757 1.3× 288 1.5× 11 2.9k
Mathilde Poussin United States 24 1.1k 0.7× 2.1k 1.7× 679 0.8× 595 1.0× 97 0.5× 41 2.8k
Jurgen Corthals Belgium 28 2.3k 1.3× 1.3k 1.0× 1.4k 1.7× 332 0.6× 79 0.4× 57 2.8k
Helga Bernhard Germany 23 1.5k 0.9× 1.2k 1.0× 729 0.9× 269 0.5× 63 0.3× 51 2.4k

Countries citing papers authored by S Shu

Since Specialization
Citations

This map shows the geographic impact of S Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Shu more than expected).

Fields of papers citing papers by S Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Shu. The network helps show where S Shu may publish in the future.

Co-authorship network of co-authors of S Shu

This figure shows the co-authorship network connecting the top 25 collaborators of S Shu. A scholar is included among the top collaborators of S Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Shu. S Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Plautz, Gregory E., Gene H. Barnett, David W. Miller, et al.. (1998). Systemic T cell adoptive immunotherapy of malignant gliomas. Journal of neurosurgery. 89(1). 42–51. 112 indexed citations
3.
Chang, Alfred E., Atsushi Aruga, Mark J. Cameron, et al.. (1997). Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.. Journal of Clinical Oncology. 15(2). 796–807. 120 indexed citations
4.
Kagamu, Hiroshi, et al.. (1996). Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.. PubMed. 56(19). 4338–42. 62 indexed citations
5.
Barrett, Leah J., et al.. (1994). Seroepidemiologic Study of Cryptosporidium Infection in Children from Rural Communities of Anhui, China and Fortaleza, Brazil. American Journal of Tropical Medicine and Hygiene. 51(1). 1–10. 54 indexed citations
6.
Nabel, Gary J., E G Nabel, Zhanqiu Yang, et al.. (1994). Molecular Genetic Interventions for Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 699–707. 4 indexed citations
7.
Yoshizawa, Hirohisa, Kenjiro Ito, Hiroyuki Moriyama, et al.. (1994). Adoptive immunotherapy mediated by anti-TCR/IL-2-activated tumour-draining lymph node cells.. PubMed. 83(1). 45–51. 6 indexed citations
8.
Nabel, Gary J., E G Nabel, Zhiyong Yang, et al.. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.. Proceedings of the National Academy of Sciences. 90(23). 11307–11311. 692 indexed citations breakdown →
9.
Strome, Scott E., et al.. (1993). Immunobiologic Effects of Cytokine Gene Transfer of the B16-BL6 Melanoma. Archives of Otolaryngology - Head and Neck Surgery. 119(12). 1289–1295. 3 indexed citations
10.
Geiger, James D., Paul D. Wagner, S Shu, & Alfred E. Chang. (1992). A novel role for autologous tumour cell vaccination in the immunotherapy of the poorly immunogenic B16-BL6 melanoma. Surgical Oncology. 1(3). 199–208. 23 indexed citations
11.
Yoshizawa, Hirohisa, Alfred E. Chang, & S Shu. (1992). Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.. PubMed. 52(5). 1129–36. 49 indexed citations
12.
Yoshizawa, Hirohisa, Alfred E. Chang, & S Shu. (1991). Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. The Journal of Immunology. 147(2). 729–737. 168 indexed citations
13.
Shu, S, Ting‐Chao Chou, & Keisuke Sakai. (1989). Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.. The Journal of Immunology. 143(2). 740–748. 71 indexed citations
14.
15.
Hsieh, K. H., et al.. (1987). Lysis of primary hepatic tumours by lymphokine activated killer cells.. Gut. 28(2). 117–124. 20 indexed citations
16.
Shu, S, Ting‐Chao Chou, & Steven A. Rosenberg. (1987). Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.. The Journal of Immunology. 139(1). 295–304. 108 indexed citations
17.
Chou, Ta‐Hsu & S Shu. (1987). Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.. The Journal of Immunology. 139(6). 2103–2109. 27 indexed citations
18.
Shu, S, Ting‐Chao Chou, & Steven A. Rosenberg. (1986). In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells.. The Journal of Immunology. 136(10). 3891–3898. 74 indexed citations
19.
20.
Mulé, James J., S Shu, & S A Rosenberg. (1985). The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.. The Journal of Immunology. 135(1). 646–652. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suyu Shu Breakdown of academic impact, for papers by Glen Dranoff Breakdown of academic impact, for papers by James G. McArthur Breakdown of academic impact, for papers by Mariella Parenza Breakdown of academic impact, for papers by Judy Kantor Breakdown of academic impact, for papers by Aron D. Thall Breakdown of academic impact, for papers by Hy Levitsky Breakdown of academic impact, for papers by Mathilde Poussin Breakdown of academic impact, for papers by Jurgen Corthals Breakdown of academic impact, for papers by Helga Bernhard
Rankless by CCL
2026